In a recent clinical study conducted in Beijing, researchers are testing a treatment for patients suffering from systemic lupus erythematosus by administering autologous [the patient’s own] mesenchymal stem cells. The researchers aim to capitalize on the unique abilities of MSCs to not only differentiate into a multitude of different cell types, but to reduce the autoimmune attack in patients affected by lupus as well.
Current approaches to treat lupus comprise immunomodulators that have extremely toxic side effects. The transplantation of MSCs, however, would positively influence the white blood cells responsible for the damage caused by lupus without further stimulating the immune system. Early success in clinical trials suggests that stem cells have the potential to serve as a safe and viable therapy for patients suffering from lupus.
This research is just one example of the utility of stem cells in successfully treating diseases and injuries previously considered to be untreatable. To learn how to bank your own valuable dental pulp stem cells to insure access to emerging regenerative therapies, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™